CUSIP No:   00547W208

 

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

SCHEDULE 13G

 

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO § 240.13d-2.

 

(Amendment No. 1)*

 

Adamis Pharmaceuticals Corporation

(Name of Issuer)

 

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

 

00547W208

(CUSIP Number)

 

December 31, 2020

(Date of Event Which Requires Filing of this statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)

 

 

 *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No:   00547W208

 

(1) NAMES OF REPORTING PERSONS
 
  CVI Investments, Inc.
 
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)       ¨
  (b)       ¨
 
(3) SEC USE ONLY
 
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 
  Cayman Islands

 

NUMBER OF   (5) SOLE VOTING POWER
       
SHARES     0
       
BENEFICIALLY   (6) SHARED VOTING POWER **
       
     

4,918,972

OWNED BY      
       
EACH   (7) SOLE DISPOSITIVE POWER
       
REPORTING     0
       
PERSON WITH   (8) SHARED DISPOSITIVE POWER **
       
     

4,918,972

 

(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
   

4,918,972

   
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  ¨
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
    4.9%
   
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
  CO
   

** Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over these shares.

 

 

 

 

CUSIP No:   00547W208

 

(1) NAMES OF REPORTING PERSONS
 
  Heights Capital Management, Inc.
   
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)       ¨
  (b)       ¨
   
(3) SEC USE ONLY
 
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 
  Delaware

 

NUMBER OF   (5) SOLE VOTING POWER
 
SHARES     0
 
BENEFICIALLY   (6) SHARED VOTING POWER **
 
OWNED BY    

4,918,972

     

 

EACH   (7) SOLE DISPOSITIVE POWER
 
REPORTING     0
     
 
PERSON WITH   (8) SHARED DISPOSITIVE POWER **
 
     

4,918,972

 

 

(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
   

4,918,972

     
 
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
  ¨
   
   
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
    4.9%
     
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
  CO
   

** Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over these shares.

 

 

 

 

CUSIP No:   00547W208

 

Item 1.

 

(a) Name of Issuer

 

Adamis Pharmaceuticals Corporation (the “Company”)

 

(b) Address of Issuer’s Principal Executive Offices

 

11682 El Camino Real, Suite 300, San Diego, CA 92130

 

Item 2(a). Name of Person Filing

 

This statement is filed by the entities listed below, who are collectively referred to herein as “Reporting Persons,” with respect to the shares of common stock of the Company, $0.0001 par value per share (the “Shares”).

 

(i) CVI Investments, Inc.

 

(ii) Heights Capital Management, Inc.

 

Item 2(b). Address of Principal Business Office or, if none, Residence

 

The address of the principal business office of CVI Investments, Inc. is:

 

P.O. Box 309GT 

Ugland House

South Church Street

George Town

Grand Cayman

KY1-1104 

Cayman Islands

 

The address of the principal business office of Heights Capital Management, Inc. is:

 

101 California Street, Suite 3250 

San Francisco, California 94111

 

Item 2(c). Citizenship

 

Citizenship is set forth in Row 4 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

 

Item 2(d) Title of Class of Securities

 

Common stock, $0.0001 par value per share

 

Item 2(e) CUSIP Number

 

00547W208

 

 

 

 

CUSIP No:   00547W208

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).

 

(b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).

 

(c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).

 

(d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

 

(e) ¨ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

(f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 

(g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

 

(h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

(i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

(j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);

 

(k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

 

If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ________________

 

Item 4. Ownership

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

The information required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

 

The number of Shares reported as beneficially owned consists of Shares issuable upon the exercise of warrants to purchase Shares (the “Warrants”). The Warrants are not exercisable to the extent that the total number of Shares then beneficially owned by a Reporting Person and its affiliates and any other persons whose beneficial ownership of Shares would be aggregated with such Reporting Person for purposes of Section 13(d) of the Exchange Act, would exceed 4.99%.

 

The Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2020 indicates there were 93,657,628 Shares outstanding as of November 5, 2020.

 

Heights Capital Management, Inc., which serves as the investment manager to CVI Investments, Inc., may be deemed to be the beneficial owner of all Shares owned by CVI Investments, Inc. Each of the Reporting Persons hereby disclaims any beneficial ownership of any such Shares, except for their pecuniary interest therein.

 

Item 5. Ownership of Five Percent or Less of a Class

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: x

 

 

 

 

CUSIP No:   00547W208

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person

 

Not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control

Person

 

Not applicable.

 

Item 8. Identification and Classification of Members of the Group

 

Not applicable.

 

Item 9. Notice of Dissolution of Group

 

Not applicable.

 

Item 10. Certification

 

By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 

 

CUSIP No:   00547W208

 

SIGNATURES

 

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

 

Dated: February 10, 2021    
     
     
CVI INVESTMENTS, INC.   HEIGHTS CAPITAL MANAGEMENT, INC.
     
By: Heights Capital Management, Inc.   By: /s/ Brian Sopinsky
pursuant to a Limited Power of   Name:  Brian Sopinsky
Attorney, a copy of which was   Title:  Secretary
previously filed      
   
By: /s/ Brian Sopinsky    
Name:  Brian Sopinsky    
Title:  Secretary    
         

 

 

 

 

CUSIP No:   00547W208

 

EXHIBIT INDEX

 

EXHIBIT DESCRIPTION
I Limited Power of Attorney*
II Joint Filing Agreement*
   
* Previously filed 

 

 

 

Adamis Pharmaceuticals (NASDAQ:ADMP)
Historical Stock Chart
From Jun 2021 to Jul 2021 Click Here for more Adamis Pharmaceuticals Charts.
Adamis Pharmaceuticals (NASDAQ:ADMP)
Historical Stock Chart
From Jul 2020 to Jul 2021 Click Here for more Adamis Pharmaceuticals Charts.